Question 1

Who are the top researchers at AiCuris (Germany)?

Accepted Answer

Ranked on the quality score, Alexander Birkmann, Peter Lischka and Helga Ruebsamen‐Schaeff lead among researchers whose main affiliation is AiCuris (Germany).

Question 2

What are the most cited papers from AiCuris (Germany)?

Accepted Answer

The most cited paper from AiCuris (Germany) is "Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation" (Roy F. Chemaly, Andrew J. Ullmann, Susanne Stoelben et al., 2014), with 375 citations. Next come "The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase" (344) and "Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials" (247).

Question 3

Which research topics does AiCuris (Germany) publish most on?

Accepted Answer

By volume in 2022-now: Virus-based gene therapy research, Polyomavirus and related diseases, Parvovirus B19 Infection Studies and Viral Infections and Outbreaks Research.

Question 4

Which keywords describe research at AiCuris (Germany)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Immune Response, Vaccine, Antiviral Therapy, Encephalitis, Herpes Zoster, Herpesviruses and Vaccine Development.

Question 5

Which fields of science does AiCuris (Germany) work in?

Accepted Answer

In all years, 54% of research at AiCuris (Germany) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (53%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (10%). It does 2.1× the world's share of Life Sciences.

Question 6

Is AiCuris (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 31% lower than in 2018-2021.